Home
News
Create
Screeners
Insights
Mercury Laboratories
815.
30
+15.00
(+1.87%)
Market Cap
₹97.80 Cr
PE Ratio
20.35
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.87%
1M
+1.91%
6M
-3.14%
1Y
-1.75%
5Y
+22.34%
View Company Insights
Latest news about Mercury Laboratories
Mercury Laboratories Q3FY26 Results: Net Profit Falls 16.4% to ₹99.75 Lakhs
9 days ago
Mercury Laboratories announced mixed Q3FY26 results with quarterly net profit declining 16.4% to ₹99.75 lakhs and revenue dropping 6.2% to ₹1,835.03 lakhs. However, nine-month performance showed remarkable recovery with 77.3% profit growth to ₹360.84 lakhs. The company faced an exceptional charge of ₹39.49 lakhs due to new labour code implementation affecting gratuity calculations.
Mercury Laboratories Postpones New Injectable Plant Commissioning to December 2026
Nov 12, 2025
Mercury Laboratories Reports 70% Surge in Q2 Net Profit, Revenue Up 4.8%
Nov 12, 2025
Mercury Laboratories Appoints Seema Salvi as Head of Injectable Production Department
Nov 04, 2025
Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation